Glenmede Trust CO Na Taro Pharmaceutical Industries LTD Transaction History
Glenmede Trust CO Na
- $19.6 Billion
- Q2 2024
Shares
3 transactions
Others Institutions Holding TARO
# of Institutions
19Shares Held
694KCall Options Held
0Put Options Held
0-
Krensavage Asset Management, LLC New York, NY650KShares$012.83% of portfolio
-
Analyst Ims Investment Management Services Ltd.13.6KShares$00.02% of portfolio
-
Credit Suisse Ag Zurich, V813.1KShares$00.0% of portfolio
-
Rhumbline Advisers Boston, MA12.6KShares$00.0% of portfolio
-
Lri Investments, LLC Palm Beach Gardens, FL2KShares$00.01% of portfolio
About TARO PHARMACEUTICAL INDUSTRIES LTD
- Ticker TARO
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 37,584,600
- Description
- Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...